CURENETICS

Curenetics aims to optimise cancer treatment delivery by improving the prediction of immunotherapy treatment response, toxicity, and resistance through data-driven approaches. Our goal is to leverage clinical, genomic and histological biomarker data to develop predictive models of response to immunotherapy for cancers even before commencing treatment. We are backed by several clinical partners and advisors who work alongside us to provide us guidance and support to ensure our product has a good market fit. Our core team is made up of our CEO, CTO/data scientist, COO/AI engineer Operational and Clinical Lead and Immunologist who are working tirelessly to turn our mission into a reality